March 26, 2025
TOPLINE: Industry marketing for angiotensin receptor–neprilysin inhibitors (ARNis) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) targeted at cardiologists was associated with increased prescription of these medications but […]